JewishStatusOpen the app

Jewish News 24 · Sep 7, 2026

Jewish News 24 — photo status

🩸 ISRAELI RESEARCHERS DEVELOP PROMISING LUNG CANCER BLOOD TEST: Tel Aviv University researchers, working with JaxBio Technologies and doctors at Bnai Zion and Sheba, published a peer-reviewed study on a roughly $60 blood test that detects a chemical fingerprint on circulating DNA without costly sequencing. In a 103-person trial, it detected 93.1% of stage 2–4 lung cancers and correctly identified 90.3% of healthy controls, while also distinguishing major lung cancer subtypes. The test is not yet validated for stage 1 disease or routine screening, and a larger Israel-Europe trial is underway. Researchers say it is designed to complement CT scans, not replace them.

🩸 ISRAELI RESEARCHERS DEVELOP PROMISING LUNG CANCER BLOOD TEST: Tel Aviv University researchers, working with JaxBio Technologies and doctors at Bnai Zion and Sheba, published a peer-reviewed study on a roughly $60 blood test that detects a chemical fingerprint on circulating DNA without costly sequencing. In a 103-person trial, it detected 93.1% of stage 2–4 lung cancers and correctly identified 90.3% of healthy controls, while also distinguishing major lung cancer subtypes. The test is not yet validated for stage 1 disease or routine screening, and a larger Israel-Europe trial is underway. Researchers say it is designed to complement CT scans, not replace them.

Watch in the app All of Jewish News 24's statuses

More from Jewish News 24